Description: China Everbright Limited, an investment holding company, engages in investment activities and provides financial services in Hong Kong and Mainland China. The company invests in unlisted equity securities and/or equity derivatives, as well as in the start-up and development stage companies. It also focuses on long term equity investment in real estate, infrastructure, medical and healthcare, resources, manufacturing, technology, media, and telecom sectors. In addition, the company is involved in the private equity investment, pre-IPO financing, and structured financing for listed companies; and treasury management operations. It provides a range of financial services, including asset management, investment management, and investment advisory services related to absolute return funds, bond funds, and equity funds, as well as offers secretarial, money lending, fund management, venture capital, leasing, and consultancy services. The company was founded in 1997 and is headquartered in Hong Kong, Hong Kong, and is considered as a Red Chip company due to its listing on the Hong Kong Stock Exchange. China Everbright Limited is a subsidiary of Honorich Holdings Limited.
Home Page: www.everbright.com
Far East Finance Centre
Hong Kong,
Hong Kong
Phone:
852 2528 9882
Officers
Name | Title |
---|---|
Mr. Mingao Zhang | Pres & Exec. Director |
Mr. Hongyang Wang | VP & Exec. Director |
Mr. Yanwu Yin | VP & Exec. Director |
Mr. Zhao Zehui | Sr. Investment Director |
Mr. Ming Kin Chan | Gen. Counsel |
Ms. Kim Ying Wan | Company Sec. and Director of Company Secretarial of Legal, Compliance & Company Secretarial |
Ms. Shengyan Fan | MD of M&A Department & Managing Partner of CEL Catalyst China Israel Fund |
Mr. John Chan | MD of M&A Department & Managing Partner of CEL Catalyst China Israel Fund |
Ms. Jane Zhang | Managing Director of Fund of Funds Investment Team |
Mr. Yizhe Wang | Managing Director of Super Acquisition Fund Department II |
Exchange: PINK
Country: US
Currency: US Dollar ($)
Forward PE: | 0 |
---|---|
Trailing PE: | 3.9589 |
Price-to-Book MRQ: | 0.2158 |
Price-to-Sales TTM: | 3.4885 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 273 |